Login / Signup

Predictive Factors for Efficacy of AST-120 Treatment in Diabetic Nephropathy: a Prospective Single-Arm, Open-Label, Multi-Center Study.

You Cheol HwangSe Won KimKyu-Yeon HurBong Soo ChaIn Joo KimTae Sun ParkSei Hyun BaikKun-Ho YoonKwan-Woo LeeIn-Kyu LeeMoon Kyu Lee
Published in: Journal of Korean medical science (2019)
The addition of AST-120 to conventional treatments may delay the progression of renal dysfunction in diabetic nephropathy. The antioxidant effect of AST-120 might contribute to improvement in renal function.
Keyphrases
  • diabetic nephropathy
  • open label
  • oxidative stress
  • clinical trial
  • squamous cell carcinoma
  • phase iii
  • rectal cancer